| |
|
|
| Name: |
COMMODORE CAPITAL LP |
| City: |
NEW YORK |
| State: |
NY |
| Zip: |
10153 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
12 |
|
View All Holdings |
Currently
Viewing:
Increased Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
NUVL |
Nuvalent, Inc. |
3 |
- |
$0.00 |
$111,716,000 |
1,487,756 |
7.47% |
13,765,000 |
156,719 |
2.262 |
N/A |
|
|
ELVN |
Enliven Therapeutics Ord Shs |
6 |
- |
$0.00 |
$69,889,000 |
3,973,245 |
4.67% |
29,728,000 |
1,071,429 |
9.641 |
N/A |
|
|
ARVN |
Arvinas Holding Company, Llc |
10 |
- |
$34.65 |
$52,632,000 |
1,275,000 |
3.52% |
11,472,000 |
275,000 |
1.854 |
N/A |
|
|
COGT |
Cogent Biosciences, Inc. |
12 |
- |
$7.92 |
$43,176,000 |
6,425,000 |
2.89% |
10,448,000 |
858,974 |
6.782 |
N/A |
|
|
PHVS |
Pharvaris N V Ord Shs |
13 |
- |
$0.00 |
$39,865,000 |
1,725,000 |
2.67% |
17,425,000 |
925,000 |
4.165 |
N/A |
|
|
CLDX |
Celldex Therapeutics Inc |
14 |
- |
$37.67 |
$36,366,000 |
866,468 |
2.43% |
8,526,000 |
164,501 |
1.378 |
Diagnostic Substances |
|
|
NKTX |
Nkarta, Inc. |
15 |
- |
$0.00 |
$34,214,000 |
3,165,000 |
2.29% |
16,196,000 |
435,000 |
6.504 |
N/A |
|
|
VRDN |
Viridian Therapeutics Ors Shs |
16 |
- |
$12.88 |
$33,876,000 |
1,934,653 |
2.27% |
-8,030,000 |
10,579 |
3.085 |
N/A |
|
|
KURA |
Kura Oncology Inc |
18 |
- |
$22.11 |
$32,528,000 |
1,525,000 |
2.18% |
14,581,000 |
276,938 |
1.821 |
N/A |
|
|
APGE |
Apogee Therapeutics, Inc. |
26 |
- |
$49.21 |
$19,271,000 |
290,000 |
1.29% |
12,286,000 |
40,000 |
0.604 |
N/A |
|
|
THRD |
Third Harmonic Bio, Inc. |
29 |
- |
$15.54 |
$11,800,000 |
1,250,000 |
0.79% |
4,047,000 |
543,294 |
3.083 |
N/A |
|
|
SNDX |
Syndax Pharmaceuticals Inc |
33 |
- |
$20.66 |
$7,589,000 |
318,851 |
0.51% |
7,589,000 |
318,851 |
0.339 |
N/A |
|
